09:01 AM EDT, 09/18/2024 (MT Newswires) -- Altamira Therapeutics ( CYTO ) shares were down about 5% in Wednesday's premarket activity after it priced a public offering of 5.6 million common shares and two tranches of pre-funded warrants to purchase up to 11.2 million shares at $0.72 per share or warrant.

The offering is expected to close Thursday.

The company intends to use net proceeds from the offering for general corporate purposes.

Price: 0.7520, Change: -0.04, Percent Change: -4.79